Nicolas Wein
Impact in
- Genetics top 10%
- Neurogenetic and Muscular Disorders Research
- Virus-based gene therapy research
Papers in
-
- Muscle Physiology and Disorders 25
- RNA Research and Splicing 9
- CRISPR and Genetic Engineering 6
- RNA regulation and disease 5
- RNA modifications and cancer 5
- Genetics 9
- Virus-based gene therapy research 7
- Neurogenetic and Muscular Disorders Research 5
- Co-authors
- Kevin M. Flanigan (17 shared papers)Florian Barthélémy (3 shared papers)Nicolas Lévy (7 shared papers)Marc Bartoli (7 shared papers)Martin Krahn (6 shared papers)Lindsay N. Alfano (1 shared paper)Adeline Vulin (5 shared papers)Nianyuan Huang (6 shared papers)
- Journals
- Neuromuscular Disorders (6 papers)Human Gene Therapy (3 papers)Molecular Therapy — Methods & Clinical Development (3 papers)Human Mutation (3 papers)Molecular Therapy (2 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Nicolas Wein
33 papers receiving 674 citations
Peers
Comparison fields: 5 of 64
- Genetics 134
- Aging 18
- Molecular Biology 639
- Cardiology and Cardiovascular Medicine 126
- Genetics 146
Countries citing papers authored by Nicolas Wein
This map shows the geographic impact of Nicolas Wein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Wein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Wein more than expected).
Fields of papers citing papers by Nicolas Wein
This network shows the impact of papers produced by Nicolas Wein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Wein. The network helps show where Nicolas Wein may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Wein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 62 | |
| 2 | 2010 | 59 | |
| 3 | 2015 | 56 | |
| 4 | 2018 | 45 | |
| 5 | 2015 | 37 | |
| 6 | 2011 | 36 | |
| 7 | 2011 | 30 | |
| 8 | 2015 | 30 | |
| 9 | 2021 | 27 | |
| 10 | 2015 | 27 | |
| 11 | 2017 | 25 | |
| 12 | 2015 | 23 | |
| 13 | 2020 | 22 | |
| 14 | 2023 | 21 | |
| 15 | 2021 | 21 | |
| 16 | 2013 | 21 | |
| 17 | 2022 | 20 | |
| 18 | 2020 | 13 | |
| 19 | 2021 | 13 | |
| 20 | 2021 | 13 |
About Nicolas Wein
Nicolas Wein is a scholar working on Molecular Biology, Genetics, Genetics, Cardiology and Cardiovascular Medicine and Surgery, having authored 34 papers that have together received 684 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (25 papers), RNA Research and Splicing (9 papers), Virus-based gene therapy research (7 papers), CRISPR and Genetic Engineering (6 papers), RNA regulation and disease (5 papers), Neurogenetic and Muscular Disorders Research (5 papers), RNA modifications and cancer (5 papers) and Cardiomyopathy and Myosin Studies (4 papers). The work is most often cited by research in Genetics (134 citations), Aging (18 citations), Molecular Biology (639 citations), Cardiology and Cardiovascular Medicine (126 citations) and Genetics (146 citations). Nicolas Wein has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Kevin M. Flanigan, Florian Barthélémy, Nicolas Lévy, Marc Bartoli, Martin Krahn, Lindsay N. Alfano, Adeline Vulin, Nianyuan Huang, Andrew R. Findlay and Luis Garcı́a. Their work appears in journals such as Neuromuscular Disorders, Human Gene Therapy, Molecular Therapy — Methods & Clinical Development, Human Mutation and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.